NCT01288469[Secondary Source ID] - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2012	1
2016	1
2018	1
2026	0

Page 1

Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia.

Roth EM, McKenney JM, Hanotin C, Asset G, Stein EA. Roth EM, et al. N Engl J Med. 2012 Nov 15;367(20):1891-900. doi: 10.1056/NEJMoa1201832. Epub 2012 Oct 31. N Engl J Med. 2012. PMID: 23113833 Free article. Clinical Trial.

Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo.

Toth PP, Hamon SC, Jones SR, Martin SS, Joshi PH, Kulkarni KR, Banerjee P, Hanotin C, Roth EM, McKenney JM. Toth PP, et al. Lipids Health Dis. 2016 Feb 13;15:28. doi: 10.1186/s12944-016-0197-4. Lipids Health Dis. 2016. PMID: 26872608 Free PMC article. Clinical Trial.

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials.

Leiter LA, Tinahones FJ, Karalis DG, Bujas-Bobanovic M, Letierce A, Mandel J, Samuel R, Jones PH. Leiter LA, et al. Diabet Med. 2018 Dec;35(12):1742-1751. doi: 10.1111/dme.13817. Epub 2018 Oct 9. Diabet Med. 2018. PMID: 30183102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year